Suchergebnisse - "Norton, Thomas"

PubPharm (167)

31

LENTIVIRAL VECTORS AND METHODS OF USE THEREOF

enthalten in: Europäisches Patentamt | 2018

von LANDAU NATHANIEL R | SUNSERI NICOLE | NORTON THOMAS D

32

Axial Elongation in Myopic Children and its Association With Myopia Progression in the Correction of Myopia Evaluation Trial

enthalten in: Eye & contact lens | 2018

von Hou, W. | Norton, T. | Hyman, L. | +2

33

The hyperopic effect of narrow-band long-wavelength light in tree shrews increases non-linearly with duration

enthalten in: Vision research | 2018

von Ward, A. | Norton, T. | Huisingh, C. | +1

34

Altered gene expression in tree shrew retina and retinal pigment epithelium produced by short periods of minus-lens wear

enthalten in: Experimental eye research | 2018

von He, L. | Frost, M. | Siegwart, J. | +1

35

Correction to : Phase II study of bi-weekly temozolomide plus bevacizumab for adult patients with recurrent glioblastoma

enthalten in: Cancer chemotherapy and pharmacology | 2018

von Badruddoja, M. | Pazzi, M. | Sanan, A. | +6

ErratumFor: Cancer Chemother Pharmacol. 2017 Oct;80(4):715-721. - PMID 28808777

36

Long-wavelength (red) light produces hyperopia in juvenile and adolescent tree shrews

enthalten in: Vision research | 2017

von Gawne, T. | Ward, A. | Norton, T.

37

Phase II study of bi-weekly temozolomide plus bevacizumab for adult patients with recurrent glioblastoma

enthalten in: Cancer chemotherapy and pharmacology | 2017

von Badruddoja, M. | Pazzi, M. | Sanan, A. | +6

ErratumIn: Cancer Chemother Pharmacol. 2018 Jan;81(1):223. - PMID 29034406

38

Correction to: Phase II study of bi-weekly temozolomide plus bevacizumab for adult patients with recurrent glioblastoma

enthalten in: Cancer chemotherapy and pharmacology | 2017

von Badruddoja, M. | Pazzi, M. | Sanan, A. | +6

39

Correction to: Phase II study of bi-weekly temozolomide plus bevacizumab for adult patients with recurrent glioblastoma

enthalten in: Cancer chemotherapy and pharmacology | 2017

von Badruddoja, M. | Pazzi, M. | Sanan, A. | +6

40

Correction to: Phase II study of bi-weekly temozolomide plus bevacizumab for adult patients with recurrent glioblastoma

enthalten in: Cancer chemotherapy and pharmacology | 2017

von Badruddoja, M. | Pazzi, M. | Sanan, A. | +6